CANCER ANTIGENS - OTHER
Let the assistant research this device
The Research Assistant compiles risk class, certificates, notified bodies and related records — and cites every one.
Free to try · every answer cites its records
Basic Information
- Primary DI
- 06974671100106
- Basic UDI-DI Code
- B-06974671100106
- Reference
- DR-CM-A019
- Device Types
- None provided
- Regulation
- Eu Ivdd
- Classification
- Eu Ivd General
- Status
- On The Market
- Manufacturer
- Darui Biotechnology Co., Ltd.
Additional Description
This kit is intended for quantitative detection of carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in human serum. It is mainly used for dynamic monitoring of patients with malignant tumors to assist in evaluating disease progression or treatment effects. It should not be used as the basis for the early diagnosis or confirmation of malignant tumors or used for tumor screening in the general population. This kit can be used to determine the level of tumor markers such as CEA and AFP that require dynamic monitoring in the treatment of patients with malignant tumors and to monitor the treatment of patients.
CND Nomenclature Codes
| Code | Description |
|---|---|
| W0102030199 | CANCER ANTIGENS - OTHER |
Similar Devices
Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).